AzTrials
AzTrials

Mental Health IssueNCT06451549

Clinical Investigation of Syndi

A study testing Syndi recommender system for mental health apps in people with Mental Health Issue and Depression, run by Newcastle University at 4 sites in United Kingdom.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Mental health concerns are a growing global concern, but support can still be difficult to access. Digital health technologies can help people access support, but with over 10,000 mental health apps available, it can be difficult to choose one that is safe, effective, and personalised. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mental Health Issue, Depression, Anxiety
What is being tested?
Syndi recommender system for mental health apps
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
4 sitesUnited Kingdom
Study dates
1 Aug 2024to Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Based in the UK
  • Referred or self-referred to proceed through the standard NHS Talking Therapies care pathway OR people with mental health concerns looking for app recommendations online;
  • Willing and able to provide informed consent;
  • Aged 18 years or older;
  • Able to speak English;
  • Have access to the internet and own a smartphone.

Who cannot join

  • Patients with a PHQ-9 score >=20
  • Patients with suicidal ideation measured as an answer of 'YES' to any question in the Columbia Suicide Severity Rating Scale (C-SSRS);
  • Incapable of self-consent;
  • In a dependent/unequal relationship with the research or care teams or any PPI representatives.

Trial locations and contacts

4 sites in 1 country.

United Kingdom4 sites
  • Pennine Care NHS Foundation Trust

    Ashton-under-Lyne, Lancashire, OL6 7SR

  • Cornwall Partnership NHS Foundation Trust

    Bodmin, PL31 2QN

  • Devon Partnership NHS Trust

    Exeter, EX2 5AF

  • Newcastle University

    Newcastle upon Tyne, Tyne and Wear, NE1 7RU

Other trials in United Kingdom

About this study

Official title: Real-world Evaluation of a Recommender System for Mental Health Self-management

Mental health concerns are a growing global concern, but support can still be difficult to access. Digital health technologies can help people access support, but with over 10,000 mental health apps available, it can be difficult to choose one that is safe, effective, and personalised. Syndi is a digital health platform that uses a machine learning system to provide personalised recommendations of mental health apps. This study aims to examine the impact of Syndi and its recommendations on the mental health and well-being of people with mental health concerns.

The investigators will use the standard National Health Service (NHS) Talking Therapies measures of anxiety and depression, as well as additional measures of wellbeing and functional impairment to look at the impact of Syndi on patients' mental well-being. The investigators will also look at user experience with Syndi using a survey. Users' engagement with Syndi and its recommended apps will be assessed using a short survey and some participants will be randomly selected for an interview so the investigators can get a better understanding of what people liked and disliked about using the platform and why.

The investigators expect that the project will show that using Syndi helps improve mental well-being in people with mental health concerns. If the study shows this positive impact, this will provide evidence to support the use of Syndi to improve the accessibility of mental health support in clinical pathways. The investigators will publish the results of the study in academic journals as well as in more accessible platforms.

Being tested
Syndi recommender system for mental health apps
Keywords
Digital Health, Recommender System, Mental Health, Telemedicine
Medical subject headings
Depression, Anxiety Disorders, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Syndi recommender system for mental health appsDevice

    Syndi is a mental health app recommendation system. It provides personalised suggestions of apps to help users self-manage their mental health based on a clinical assessment.

Study groups in NCT06451549
Study groupRoleWhat they receive
Syndi recommender system for mental health appsExperimentalSyndi is a recommender system for mental health apps, delivered via a website. It guides users through a clinically-validated self-assessment and uses a machine learning system to provide personalised recommendations of independently-rated mental health tools.
Receives: Device: Syndi recommender system for mental health apps

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression Severity

    Score on the Patient Health Questionnaire-9 (PHQ-9), total scores range from 0 to 27 (higher scores indicate more severe depression)

    Measured: 2 weeks and 3 months post-baseline

Secondary outcomes (7)
  1. Anxiety Severity

    Score on the Generalised Anxiety Disorder-7 (GAD-7), total scores range from 0 to 21 (higher scores indicate more severe anxiety)

    Measured: 2 weeks and 3 months post-baseline

  2. Mental Wellbeing

    Score on the Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS), total scores range from 7 to 35 (higher scores indicate better wellbeing)

    Measured: 2 weeks and 3 months post-baseline

  3. Functional Impairment

    Score on the Work and Social Adjustment Scale (WSAS), total scores range from 0 to 40 (higher scores indicate higher functional impairment)

    Measured: 2 weeks and 3 months post-baseline

  4. Engagement with recommended apps

    Self-report questionnaire about engagement with recommended apps (subjective, with questions about which apps were downloaded, how long they used it for, and how useful they found the app)

    Measured: 2 weeks post-baseline

  5. User experience with the Syndi recommender system

    Score on a user experience questionnaire. Items were assessed individually on a scale from 1-5, with higher scores indicating better experience (negative items were reverse coded)

    Measured: Immediately after app recommendations and at 2 weeks post-baseline

  6. User perceptions of the system

    Qualitative feedback from semi-structured interviews about Syndi

    Measured: Semi-structured interview call, 2 months after start of the trial

  7. User perceptions of the recommended apps

    Qualitative feedback from semi-structured interviews about the apps recommended by Syndi

    Measured: Semi-structured interview call, 2 months after start of the trial

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2024
  2. Study start1 Aug 2024 (estimated)
  3. Primary completionNov 2024 (estimated)
  4. Study completionNov 2024 (estimated)

Why it stopped: The study has been withdrawn due to significant changes in its scope, which no longer align with the original protocol.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
All participants will be given access to Syndi immediately
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06451549
Sponsor's protocol ID
NU-015775
Status last verified
Feb 2025
First submitted
4 Jun 2024
Last updated
6 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Only the Academic CIs and their research staff will have access to research data.

Questions about this trial

What is this clinical trial studying?

A study testing Syndi recommender system for mental health apps in people with Mental Health Issue and Depression, run by Newcastle University at 4 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 6 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression Severity (time frame: 2 weeks and 3 months post-baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in